Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. - Wikidata - awgldk - TriplyDB

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

http://www.wikidata.org/entity/Q36908403

about

Androgen Receptor: A Complex Therapeutic Target for Breast Cancer Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.Down-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.Curcumin: a calixarene derivative micelle potentiates anti-breast cancer stem cells effects in xenografted, triple-negative breast cancer mouse models.The regulatory role of miRNAs on VDR in breast cancer.Vitamin D exposure and Risk of Breast Cancer: a meta-analysis.

P2860

Q28075188-3C181E0D-E502-41D4-9206-7F635DB52044 Q30490897-8C43690B-BA9B-4DE6-82E6-348A4C74655A Q33587654-C3F2E04F-1143-4B4E-9342-88D27E60D4BA Q37534790-7509AB7A-5CA2-4F35-B810-EE7A91ECD749 Q37557965-B4842CA5-D264-41F4-8DFF-FFD228C1DB59 Q38399495-07ACEAA6-EF7A-45C4-89B4-80D56EEBC4B1 Q47114555-BCDBB81B-4995-405C-A212-44EB3023A8A7 Q47572448-202FC06F-F171-4069-93B9-DF8971017033 Q47623996-E550916F-0D59-4C86-8407-36E84EE60110 Q48300428-8FB6B72C-40A4-48FE-AD0C-9709978A0838 Q55299157-88BA9B8A-6CA5-4148-BFB9-8BE9709CABFF

P2860

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

http://www.wikidata.org/entity/Q36908403

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

@en

type

label

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

@en

prefLabel

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

@en

P1433

Q36908403-FB5B6B03-149D-4ECA-A4FB-63C2C90C0F6F

P1476

Q36908403-8BEDAF62-9B51-4CEF-B4AB-5DDE705329E8

P2093

Q36908403-2B64880E-3C92-4EDD-834C-6095FB463607

Q36908403-632A2896-66B2-439B-9E0D-E9833F7536B9

Q36908403-BA6DB53A-25E0-4A50-9627-7BFC6BEEC628

P2860

Q36908403-04FDD0A1-022C-454B-95DD-AB9D10F5A551

Q36908403-0635F48D-3CA0-4F8C-B30B-18240DD9F24B

Q36908403-08179E29-569C-4680-957F-7370B7C18891

Q36908403-0A9EC60D-2A5B-48B8-99C9-5A5018B235EF

Q36908403-0CE3B1BA-639D-487D-9F8C-FA9B38A142B5

Q36908403-0EF77874-AE3B-46AA-BE0F-8BDB46281A76

Q36908403-0EFAEEF4-1CBF-451A-A2B8-68E8B281AC5A

Q36908403-100EFED0-E7BC-4E85-B796-162FD033E78C

Q36908403-1620EC5C-1844-46A3-B52C-F0327D531D7E

Q36908403-1ADA05A7-077B-4857-88DD-ED208AFD8219

P2888

Q36908403-19CEFFCF-468B-4A5A-87CA-6DF547CB0C35

P304

Q36908403-8AB79080-3F5D-4820-99B8-7BD1709CC896

P31

Q36908403-61A716A4-DCB8-4F6E-929D-599E99C0F6F7

P356

Q36908403-C2E2497D-F5BB-436C-9867-92179EF68DCA

P407

Q36908403-13911B60-5541-46E2-B241-0954376C7853

P433

Q36908403-3322AA95-1953-4905-8F19-2F36C0FA8407

P478

Q36908403-0A8BDCEF-8C80-4E58-840A-16BC95E26738

P50

Q36908403-8B5341C2-42DF-463D-8FD1-91E71E685CF1

Q36908403-98DEA344-DAB9-48CC-AC25-7290D3798CC7

P577

Q36908403-5A580F15-7D7F-43BF-862C-8F4E246538A4

P5875

Q36908403-7A22D56F-258A-459F-A97A-03B5E29EAAC9

P698

Q36908403-3364E54E-6A44-4439-9E8C-6940F30E494F

P921

Q36908403-F2095FF0-87AE-4190-A854-FA7FE313F510

P932

Q36908403-B73391BD-E526-4F2F-8B95-82DBFE4288FA

P356

S10549-016-3807-Y

P1433

Breast Cancer Research and Treatment

P1476

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.

@en

P2093

A Thakkar

http://www.w3.org/2001/XMLSchema#string

B Wang

http://www.w3.org/2001/XMLSchema#string

Tan A Ince

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Targeting androgen receptor in estrogen receptor-negative breast cancer

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Of mice and women: a comparative tissue biology perspective of breast stem cells and differentiation

Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant Therapy

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Cisplatin: mode of cytotoxic action and molecular basis of resistance

P2888

s10549-016-3807-y

P304

77-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-016-3807-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Picon-Ruiz

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301685865

http://www.w3.org/2001/XMLSchema#string

P698

27120467

http://www.w3.org/2001/XMLSchema#string

P921

P932

4869778

http://www.w3.org/2001/XMLSchema#string